Loading company…
Won 3 federal SBIR/STTR research awards from HHS and other federal agencies.
Antiger Therapeutics Inc. has been awarded 3 US Small Business Innovation Research (SBIR/STTR) contracts totalling $869,457 between 2023 and 2025. These are non-dilutive federal research grants, not equity financing. The company is based in SAINT LOUIS, Missouri.
No investors recorded yet for Antiger Therapeutics Inc..
Add an investorAntiger Therapeutics Inc. has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for Antiger Therapeutics Inc..
Add diversity data